Distinct plasma immune signatures in ME/CFS are present early in the course of illness (Science Advances)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an unexplained incapacitating illness that may affect up to 4 million people in the United States alone. There are no validated laboratory tests for diagnosis or management despite global efforts to find biomarkers of disease. We considered the possibility that inability to identify such biomarkers reflected variations in diagnostic criteria and laboratory methods as well as the timing of sample collection during the course of the illness.

Read the full article, with full findings and data, on Science Advances (27th Feb 2015)

Comments are closed.